News

LiquiColl is a liquefied collagen gel developed for tissue engineering and localized delivery of therapeutic agents. It is comprised of native fibrillar collagen dispersed and stabilized in buffered

For adults and teens, the FDA’s decision brings a first-ever treatment for infections caused by the waterborne protozoan that is recognized as widespread in the US. Cryptosporidium is

The study’s findings are important because the onset of damage caused by sickle cell anemia (SCA) complications can occur as early as three months after birth. Starting treatment

Under this agreement, Acologix is granted an exclusive license to develop and commercialize TRK-820 in North America. In Europe, Acologix and Toray will co-develop the compound and Acologix

A completed a special protocol documents the FDA’s agreement that the design and planned analysis of the Study adequately addresses objectives in support of a regulatory submission such

The company said the new product, dubbed PRM R11, includes its Practice Management and Electronic Health Record (EHR) technology. The updated version was developed in response to physician

Premenstrual dysphoric disorder (PMDD) affects approximately 5% of menstruating women according to Metabolon. Symptoms of the disorder include marked depression, anxiety, tension, irritability and moodiness. Considered a mood

The newly granted patent includes broad claims covering therapeutic use of double-stranded RNA expressed from endogenous templates or expression vectors to mediate RNA interference (RNAi). This is the

Under the definitive merger agreement, Pfizer will acquire all outstanding shares of Vicuron common stock at a price of $29.10 per share in cash, for an aggregate equity